A Switch To ViiV's Two-Drug Dovato Keeps HIV Suppressed

07:22 EDT 10 Jul 2019 | SCRIP

Top-line results from the Phase III TANGO study suggests that switching to ViiV’s two-drug Dovato from a three-drug regimen does...


Related Stories


Original Article: A Switch To ViiV's Two-Drug Dovato Keeps HIV Suppressed


More From BioPortfolio on "A Switch To ViiV's Two-Drug Dovato Keeps HIV Suppressed"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...